Last Updated on October 15, 2024 by The Health Master
Sun Pharmaceutical Industries on Thursday said it has received final approval from the US health regulator for Mesalamine extended release capsules, used to treat bowel disease, in the American market.
The company has received approval from the US Food and Drug Administration (USFDA) for the product, a generic version of Pentasa extended release capsules (500 mg), the Mumbai-based drug major said in a statement.
As per March 2022 IQVIA Health data, Pentasa had annualised sales of around USD 213 million in the US market.
USFDA gives approval to Alembic Pharma for Arformoterol Tartrate Inhalation Solution
USFDA gives tentative nod to Glenmark for Calcipotriene and Betamethasone Dipropionate foam
USFDA gives tentative approval for this Hypertension drug
USFDA gives tentative nod to Zydus for Selexipag tablets
USFDA gives approval to Lupin Pregabalin capsules
USFDA gives final approval to Aleor Dermaceuticals for Docosanol cream
USFDA gives approval to Alembic Pharma for Arformoterol Tartrate Inhalation Solution
High court orders removal of all Pharmacy Council members
NPPA fixes Retail Price of 84 formulations: May 2022
NPPA fixes retail price of Emcure’s HIV drug combination
USFDA gives nod to Alembic for this generic solution for Inhalation
USFDA gives 10 observations to Sun Pharm
CDSCO extends timeline for importing of drugs with shelf life less than 60%
FAQs – on Blood Bags and its Testing
USFDA gives tentative nod to Glenmark for Calcipotriene and Betamethasone Dipropionate foam
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
